Clinical Trials Logo

Filter by:
NCT ID: NCT02739711 Recruiting - Clinical trials for Acute Myocardial Infarction

Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients With Myocardial Infarction and No-reflow

REVERSE-FLOW
Start date: July 2016
Phase: Phase 4
Study type: Interventional

Aim of the study is to examine the effects of glycoprotein IIb/IIIa inhibitors on reperfusion success assessed by cardiac magnetic resonance imaging in patients with myocardial infarction and angiographic evidence of no-reflow.

NCT ID: NCT02735707 Recruiting - Clinical trials for Community-acquired Pneumonia, Influenza, COVID-19

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP
Start date: April 11, 2016
Phase: Phase 3
Study type: Interventional

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to improve outcome of patients admitted to intensive care with community-acquired pneumonia. In addition, REMAP-CAP provides and adaptive research platform for evaluation of multiple treatment modalities in the event of a respiratory pandemic such as COVID-19. REMAP-COVID is a sub-platform of REMAP-CAP that evaluates treatments specific to COVID-19 in the United States of America.

NCT ID: NCT02731859 Recruiting - Obesity Clinical Trials

EndoBarrier Register Deutschland-Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass Sleeve

EBRD
Start date: January 2014
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study ist to determine long-term safety and efficacy in weight reduction and improvement of diabetes mellitus of the temporary, endoscopic duodenal-jejunal bypass-sleeve EndoBarrier® in a national registry.

NCT ID: NCT02731001 Recruiting - Clinical trials for Non-Small Cell Lung Cancer

Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer

PRONTOX
Start date: August 2016
Phase: N/A
Study type: Interventional

The aims of the study are to reduce acute radiation induced side effects, i.e. pneumonitis and esophagitis grade II or higher by the use of proton therapy compared to photon radiotherapy of equal total dose. Secondary endpoints include evaluation of quality of life, loco-regional control, survival and late radiation induced side effects.

NCT ID: NCT02728479 Recruiting - Clinical trials for Percutaneous Transluminal Angioplasty

Percutaneous Transluminal Angioplasty Registry

Start date: January 2014
Phase:
Study type: Observational [Patient Registry]

Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease. The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.

NCT ID: NCT02724670 Recruiting - Prostate Cancer Clinical Trials

Study of MR-based IGRT for Prostate Cancer

M-basePro
Start date: March 2016
Phase: N/A
Study type: Interventional

MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.

NCT ID: NCT02724215 Recruiting - Sleep Apnea Clinical Trials

Effect of Sleep Apnea on Blood Pressure Control and Outcome Early After Subarachnoid Hemorrhage

Start date: March 2016
Phase: N/A
Study type: Observational

In this observational study patients with subarachnoid hemorrhage (SAH) will be screened for sleep apnea (SA) to investigate if SA is associated with impaired blood pressure control and worse clinical outcome early after SAH.

NCT ID: NCT02721823 Recruiting - Ulcerative Colitis Clinical Trials

Randomized Controlled Trial of Stress Reduction and Lifestyle Modification for Ulcerative Colitis

MBMCol
Start date: March 2016
Phase: N/A
Study type: Interventional

Patients with ulcerative colitis often suffer significant limitations to their quality of life, which are also conditioned by particular stress and psychosocial accompanying symptoms of the disease. A multimodal program for stress-reduction and lifestyle-modification has been shown to be effective in promoting the quality of life. The study will examine the promotion of the quality of life of patients with ulcerative colitis and the positive Influence on stress, psychological symptoms and physiological parameters. 92 patients with ulcerative colitis will be randomized in an Intervention group and a control group for 10 weeks. The primary outcome is the disease-specific quality of life, the secondary outcomes are stress, psychological symptoms, inflammatory parameters, disease activity parameters, bowel parameter and the microbiome.

NCT ID: NCT02719314 Recruiting - Osteoporosis Clinical Trials

Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis

Rh-GIOP
Start date: December 2015
Phase:
Study type: Observational [Patient Registry]

Glucocorticoids remain to be among the most important and most frequently used anti-inflammatory and immunosuppressive or immune-modulatory acting drugs to treat rheumatic (and other) diseases. Unfortunately, glucocorticoids also exert undesired effects, especially if higher dosages have to be given over longer periods of time. The available data describing frequency and severity of these adverse effects are fragmentary. This statement is especially true for glucocorticoid-induced osteoporosis (GIOP) in the context of chronic inflammatory rheumatic diseases or (in part) psoriasis(arthritis). The state of knowledge and scientific data, being sparse, is partly conflicting and often derived from over-aged projects or studies. Therefore, there are urgent needs to work on various current questions systematically and at the highest scientific level possible. In order to address these needs, we aim at collecting and analyzing disease- and bone-related data from patients with chronic inflammatory rheumatic diseases or psoriasis and therapy with glucocorticoids, and to build a respective GIOP-Databank. Patients will attend for diagnostics, and where necessary therapy and follow-up of GIOP, according to current guidelines. Clinical, laboratory and instrumental examination results from more than 1000 patients in the first three years of the project are planned to be documented in a prospective database.

NCT ID: NCT02717936 Recruiting - Clinical trials for Squamous Cell Carcinoma of the Skin

Investigation of Desmoplastic Squamous Cell Carcinoma

DesmoPEK
Start date: January 2016
Phase: N/A
Study type: Interventional

Aim of the study is to verify wether it is possible to have a more sensitive diagnostic tool using pancytokeratin immunohistochemistry for desmoplastic squamous cell carcinoma compared to regular H&E staining. The investigators therefore plan to include 73 participants with a confirmed diagnosis of desmoplastic squamous cell carcinoma and do regular follow up.